Skip to main content Accessibility help
×
Hostname: page-component-594f858ff7-pr6g6 Total loading time: 0 Render date: 2023-06-06T04:26:20.338Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": false, "coreDisableEcommerce": false, "corePageComponentUseShareaholicInsteadOfAddThis": true, "coreDisableSocialShare": false, "useRatesEcommerce": true } hasContentIssue false

C - Research in Maternal Medicine

Published online by Cambridge University Press:  04 August 2017

P. M. Shaughn O'Brien
Affiliation:
Keele University School of Medicine
Fiona Broughton Pipkin
Affiliation:
University of Nottingham
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Knight, M, Nair, M, Tuffnell, D, Kenyon, S, Shakespeare, J, Brocklehurst, P, Kurinczuk, JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care – Surveillance of maternal deaths in the UK 2012–14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–14. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2016.
Fisk, NM, Atun, R. Market failure and the poverty of new drugs in maternal health. PLoS Medicine. 2008 Jan 22;5(1):e22.
Magee, LA, von Dadelszen, P, Rey, E, et al. Less-tight versus tight control of hypertension in pregnancy. The New England Journal of Medicine. 2015 Jan 29;372(5):407–17.
von Dadelszen, P, Ornstein, MP, Bull, SB, Logan, AG, Koren, G, Magee, LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis. Lancet. 2000 Jan 8;355(9198):8792.
Magee, LA, von Dadelszen, P, Chan, S, et al. The control of hypertension in pregnancy: Study pilot trial. BJOG: An International Journal of Obstetrics and Gynaecology. 2007 Jun;114(6):770, e1320.
Rowan, JA, Hague, WM, Gao, W, Battin, MR, Moore, MP, Mi, GTI. Metformin versus insulin for the treatment of gestational diabetes. The New England Journal of Medicine. 2008 May 8;358(19):2003–15.
Chappell, LC, Gurung, V, Seed, PT, et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: Semifactorial randomised clinical trial. BMJ. 2012;344:e3799.
Johnson, M, Gatzoulis, M, Roos-Hesselink, J. Pregnancy and heart disease: time for a randomized controlled trial. International Journal of Cardiology. 2013 Oct 9;168(4):3149–51.
National Institute for Health and Clinical Excellence. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. CG107; 2010.
Veiby, G, Daltveit, AK, Engelsen, BA, Gilhus, NE. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 2009 Sep;50(9):2130–9.
Wide, K, Winbladh, B, Kallen, B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: A nation-wide, population-based register study. Acta Paediatrica. 2004 Feb;93(2):174–6.
Eriksson, K, Viinikainen, K, Monkkonen, A, et al. Children exposed to valproate in utero–population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Research. 2005 Jul;65(3):189200.
Medicines and Healthcare Products Regulatory Agency. Drug Safety Update; Medicines related to valproate: risk of abnormal pregnancy outcomes. 2015 [cited 23 January 2015]; Available from: www.gov.uk/drug-safety-update/medicines-related-to-valproate-risk-of-abnormal-pregnancy-outcomes
Sultan, AA, Tata, LJ, West, J, et al. Risk factors for first venous thromboembolism around pregnancy: A population-based cohort study from the United Kingdom. Blood. 2013 May 9;121(19):3953–61.
Williams, D. Pregnancy: a stress test for life. Current Opinion in Obstetrics & Gynecology. 2003 Dec;15(6):465–71.
Hastie, CE, Smith, GC, Mackay, DF, Pell, JP. Maternal risk of ischaemic heart disease following elective and spontaneous pre-term delivery: retrospective cohort study of 750 350 singleton pregnancies. International Journal of Epidemiology. 2011 Aug;40(4):914–9.
Hoff, JM, Daltveit, AK, Gilhus, NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies. 2007 Jan;14(1):3843.
Norwood, F, Dhanjal, M, Hill, M, et al. Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. Journal of Neurology, Neurosurgery, and Psychiatry. 2014 May;85(5):538–43.
Bonney, V. ‘Pre-eclampsia’ at the Twenty-fourth Week; Acute Toxaemia; Caesarean Section. Proceedings of the Royal Society of Medicine. 1914;7(Obstet Gynaecol Sect):118–21.
Nelson, TR. A clinical study of pre-eclampsia. I. The Journal of Obstetrics and Gynaecology of the British Empire. 1955 Feb;62(1):4857.
Torry, DS, Wang, HS, Wang, TH, Caudle, MR, Torry, RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. American Journal of Obstetrics & Gynecology. 1998 Dec; 179(6 Pt 1):1539–44.
Chappell, LC, Duckworth, S, Seed, PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013 Nov 5;128(19):2121–31.
Garg, AX, Nevis, IF, McArthur, E, et al. Gestational hypertension and preeclampsia in living kidney donors. The New England Journal of Medicine. 2015 Jan 8;372(2):124–33.
Bramham, K, Chusney, G, Lee, J, Lightstone, L, Nelson-Piercy, C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clinical Journal of the American Society of Nephrology: CJASN. 2013 Apr;8(4):563–7.
Lenz, W. Thalidomide and congenital abnormalities. Lancet. 1962;279:45.
Kim, JH, Scialli, AR. Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2011 Jul;122(1):16.
Kreft-Jais, C, Plouin, PF, Tchobroutsky, C, Boutroy, MJ. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. British Journal of Obstetrics and Gynaecology. 1988;95(4):420–2.
Bateman, BT, Patorno, E, Desai, RJ, Seely, EW, Mogun, H, Dejene, SZ, et al. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstetrics and Gynecology. 2017;129(1):174–84.
Altman, D, Carroli, G, Duley, L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet. 2002 Jun 1;359(9321):1877–90.
Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclampsia and its complications. The Cochrane Database of Systematic Reviews. 2007(2):CD004659.
Bramham, K, Parnell, B, Nelson-Piercy, C, Seed, PT, Poston, L, Chappell, LC. Chronic hypertension and pregnancy outcomes: Systematic review and meta-analysis. BMJ. 2014;348:g2301.
Redman, CW, Sargent, IL, Staff, AC. IFPA Senior Award Lecture: making sense of pre-eclampsia – two placental causes of preeclampsia? Placenta. 2014 Feb;35 Suppl:S20–5.
Roberts, JM, Bell, MJ. If we know so much about preeclampsia, why haven’t we cured the disease? Journal of Reproductive Immunology. 2013 Sep;99(1–2):19.
Krause, I, Blank, M, Gilbrut, B, Shoenfeld, Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. American Journal of Reproductive Immunology. 1993 Apr;29(3):155–61.
Dixon, PH, Wadsworth, CA, Chambers, J, et al. A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy. The American Journal of Gastroenterology. 2014 Jan;109(1):7684.
Koopmans, CM, Bijlenga, D, Groen, H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009 Sep 19;374(9694):979–88.
Strong, C. A framework for reproductive ethics. In: Dickenson, DL, editor. Ethical Issues in Maternal-Fetal Medicine. Cambridge: Cambridge University Press; 2002.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×